You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 24 No. 5, May 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Brain Uptake of Selenomethionine Se 75

I. Effects of Elevated Blood Levels of Methionine and Phenylalanine

William H. Oldendorf, MD; Warden B. Sisson, MD; Arvind C. Mehta, MD; Leo Treciokas, MD

Arch Neurol. 1971;24(5):423-430.


Abstract

Uptake of selenomethionine Se 75 after intravenous injection in rat was studied in brain, pancreas, plasma, muscle, scalp, and skull. Selenomethionine Se 75 enters rat brain by a rate-limited process with a free exchange at low blood concentrations. Acute preloading with intravenously administered nonradioactive L-methionine or L-phenylalanine results in a reduction of brain uptake of selenomethionine Se 75. Phenylalanine is a more effective inhibitor than methionine. Measurable inhibition of brain uptake of selenomethionine Se 75 is demonstrated at lower plasma levels of phenylalanine than commonly found in clinical phenylketonuria. Bidirectionality of carrier mediated exchange of selenomethionine Se 75 between blood and brain was demonstrated by ventriculocisternal perfusion studies in rabbits. The gamma emissions of selenomethionine Se 75 may be useful in clinical studies of blood brain barrier (BBB) penetration by amino acids which share the same carrier mechanism facilitating BBB passage of selenomethionine Se 75.



Author Affiliations

Los Angeles

From the Research and Medical Services (Drs. Oldendorf and Sisson), and Neurology Section, Medical Service (Dr. Mehta), Wadsworth Hospital, Veterans Administration Center, and the Department of Neurology, UCLA School of Medicine (Drs. Oldendorf, Sisson, and Treciokas), Los Angeles.


Footnotes

Accepted for publication Nov 23, 1970.

Read before the 95th annual meeting of the American Neurological Association, Atlantic City, NJ, June 17, 1970.

Reprint requests to Wadsworth General Hospital, Room C-Gr-37, Wilshire and Sawtelle Boulevards, Los Angeles 90073 (Dr. Oldendorf).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Saturation of Blood Brain Barrier Transport of Amino Acids in Phenylketonuria
Oldendorf
Arch Neurol 1973;28:45-48.
ABSTRACT  

Brain Uptake of Selenomethionine Se 75: II. Reduced Brain Uptake of Selenomethionine Se 75 in Phenylketonuria
Oldendorf et al.
Arch Neurol 1971;24:524-528.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.